Renaissance Technologies’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.4M | Buy |
929,471
+89,100
| +11% | +$2.82M | 0.04% | 552 |
|
|
2025
Q1 | $27.9M | Buy |
840,371
+271,700
| +48% | +$9.02M | 0.04% | 527 |
|
|
2024
Q4 | $19.6M | Buy |
568,671
+76,071
| +15% | +$2.62M | 0.03% | 680 |
|
|
2024
Q3 | $19.7M | Sell |
492,600
-103,200
| -17% | -$4.13M | 0.03% | 672 |
|
|
2024
Q2 | $18M | Buy |
595,800
+215,700
| +57% | +$6.51M | 0.03% | 644 |
|
|
2024
Q1 | $12.8M | Buy |
380,100
+121,600
| +47% | +$4.08M | 0.02% | 862 |
|
|
2023
Q4 | $8.35M | Sell |
258,500
-33,600
| -12% | -$1.09M | 0.01% | 1038 |
|
|
2023
Q3 | $9.57M | Sell |
292,100
-118,300
| -29% | -$3.88M | 0.02% | 948 |
|
|
2023
Q2 | $14.4M | Sell |
410,400
-55,400
| -12% | -$1.95M | 0.02% | 837 |
|
|
2023
Q1 | $15.2M | Buy |
465,800
+123,100
| +36% | +$4.02M | 0.02% | 866 |
|
|
2022
Q4 | $18.9M | Buy |
342,700
+17,700
| +5% | +$975K | 0.03% | 734 |
|
|
2022
Q3 | $14.4M | Buy |
325,000
+33,200
| +11% | +$1.47M | 0.02% | 841 |
|
|
2022
Q2 | $14.2M | Buy |
291,800
+149,300
| +105% | +$7.28M | 0.02% | 915 |
|
|
2022
Q1 | $6.93M | Buy |
142,500
+7,700
| +6% | +$375K | 0.01% | 1369 |
|
|
2021
Q4 | $5.75M | Buy |
134,800
+95,400
| +242% | +$4.07M | 0.01% | 1439 |
|
|
2021
Q3 | $1.51M | Buy |
39,400
+27,600
| +234% | +$1.06M | ﹤0.01% | 2306 |
|
|
2021
Q2 | $333K | Buy |
+11,800
| New | +$333K | ﹤0.01% | 3109 |
|